CVRx Stock

cvrx.comHealthcare / Other HealthcareFounded: 1900Funding to Date: $384.4MM

CVRx is the developer of a proprietary implantable technology for the treatment of high blood pressure and heart failure

Register for Details

For more details on financing and valuation for CVRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for CVRx.

Register Today

Team

Management Team

John Brintnall
Chief Financial Officer
Julia Stubben
Vice President, European Sales & Marketing
Nadim Yared
President, Chief Executive Officer & Board Member
Joseph DuPay
Senior Vice President, Development & Operations
Jared Oasheim
Controller
Dean Bruhn-Ding
Vice President of Regulatory Affairs and Quality Assurance

Board Members

Geoff Pardo
Gilde Healthcare Partners
Ali Behbahani MD
New Enterprise Associates
John Nehra
New Enterprise Associates
Kadir Kadhiresan Ph.D
Johnson & Johnson Innovation - JJDC
Tom Heyman
Johnson & Johnson Innovation - JJDC
Claudia D'Augusta Ph.D
Ysios Capital
Juan-Pablo Mas
Action Potential Venture Capital
Joseph Slattery
Nadim Yared

Other companies like CVRx in the Other Healthcare sector

Sector
Last Round Est. Valuation
$165MM
Sector
Last Round Est. Valuation
$368.08MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$125MM
Sector
Last Round Est. Valuation
$140MM
Sector
Last Round Est. Valuation
$300.91MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$173.59MM

News Highlights

At long last, CVRx device gets FDA approval
Barostim device gets FDA nod to treat heart failure by stimulating nerve endings in the neck
CVRx President and CEO Nadim Yared Named Chairman of the Medical Device Innovation Consortium (MDIC) Board of Directors
CVRx® Secures $113 Million in New Financing
/PRNewswire/ -- CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans...
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.